DWM
FLNA

Darwin Wealth Management’s Filana Therapeutics FLNA Stock Holding History

Darwin Wealth Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,293
Closed -$214K – 175
2022
Q4 		$214K Hold
6,293
– – 0.06% 158
2022
Q3 		$226K Buy
+6,293
New +$170K 0.06% 144
2022
Q2 		– Sell
-6,293
Closed -$234K – 176
2022
Q1 		$234K Buy
+6,293
New +$267K 0.04% 157

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Darwin Wealth Management's FLNA Position: Q1 2023 in Review

Darwin Wealth Management sold out of Filana Therapeutics (FLNA) in Q1 2023, closing a stake of 6,293 shares — an estimated $214K sold.

Darwin Wealth Management first reported a position in FLNA in Q1 2022 and held it in 3 quarters. The position peaked at $234K in Q1 2022. 145 funds tracked by Wall St. Rank hold FLNA as of Q1 2023.

  • Darwin Wealth Management reported no remaining Filana Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Darwin Wealth Management sold 6,293 Filana Therapeutics shares in Q1 2023, an estimated $214K.
  • Darwin Wealth Management first reported a position in Filana Therapeutics in Q1 2022 and held it in 3 quarters.
  • Darwin Wealth Management's Filana Therapeutics position peaked at $234K in Q1 2022.
  • 145 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2023.

Based on Darwin Wealth Management's 13F filing for Q1 2023, filed 18 Apr 2023.